RxDoctor Payments Data

Arvind Rengarajan, MD

Gastroenterology · Saint Louis, MONPI 1427430057

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,021 of the $53,428 with a category attached, or 93.6%. Boston Scientific accounts for 95.7% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $50,640, more than ten times the $145 reported in 2019. Among gastroenterology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,428in general payments, 2019–2025

Across 30 payments — averaging $1780.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$51K
  • Ovesco Endoscopy USA, Inc.$740
  • Medtronic$440
  • Olympus America Inc.$327
  • ERBE USA Inc$140
  • Conmed Corporation$128
  • plus $509 from 6 others

What the payments were for

  • Grants$50,02194%
  • Travel & lodging$7401%
  • Food & beverage$2,6675%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,428 in reported general payments places this provider in the 90th percentile of 374 gastroenterology providers in Missouri.

See all gastroenterology providers in Missouri

Medicare billing

Part B allowed, 2024
$95,463
Medicare patients
257
Services billed
564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MotegrityPrucalopride Succinate17$8,987
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates15$949
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl64$849
Omeprazole82$849
Sucralfate14$831
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl21$353
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl20$323
Ciprofloxacin Hcl22$71
Pantoprazole Sodium14$69

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →